Latest stories

  • in

    Abbott signals recovery in device sales as hospital staff shortages ease

    United States: Abbott Laboratories said on Wednesday most delayed non-urgent medical procedures had resumed globally three years into the COVID-19 pandemic as hospital staff shortages eased and customers became regular with check-ups, sending shares up 7%. The much-awaited recovery in elective surgeries led the company to effectively raise forecast for its core business, even as COVID […] More

  • in

    USFDA clears reader for Abbott FreeStyle Libre 3 system

    USFDA clears reader for Abbott FreeStyle Libre 3 system

    Abbott Park, Ill.: Abbott has announced that the U.S. Food and Drug Administration (FDA) has cleared a reader for its FreeStyle Libre 3 integrated continuous glucose monitoring (iCGM) system, which features the smallest, thinnest and most discreet glucose sensor. “With the FDA’s clearance of a standalone reader, Abbott is working to get the FreeStyle Libre 3 system added […] More